9,10-Dihydro-7H-imidazo[2',1':2,3]imidazo[4,5-f]quinoxaline
Brimonidine Cyclic Impurity is a fully characterized chemical compound used as a reference standard of API Brimonidine. The standard offered is compliant with regulatory guidelines. Brimonidine Cyclic Impurity is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Brimonidine 2,3-Dione Impurity hydrochloride
M.F. C₁₁H₁₀BrN₅O₂. HCl
M.W. 324.14 36.46
CAT# AR-B01991
CAS# 182627-95-8 (free base)
O-Isopropyl (5-bromoquinoxalin-6-yl)carbamothioate
M.F. C₁₂H₁₂BrN₃OS
M.W. 326.2
CAT# AR-B05524
CAS# 2742962-04-3
Brimonidine O-Isopropyl Ethanethioate Impurity
M.F. C₁₂H₁₂BrN₃OS
M.W. 326.21
CAT# AR-B05664
CAS# 2742962-04-3
Brimonidine EP Impurity G Trifluoroacetic Acid Salt
M.F. C₁₁H₁₂BrN₅O; CF₃CO₂H
M.W. 310.16; 114.02
CAT# AR-B05503
CAS# 1391054-10-6
